What it USCAP ?
The United States and Canadian Academy of Pathology, abbreviated USCAP, is the largest North American organization of pathologists. It is the publisher to two major pathology journals, Laboratory Investigation and Modern Pathology.
Mesenchymal tumors are inherently diagnostically challenging, but a significant practice gap in their interpretation has developed as new entities and genetic abnormalities have emerged. Diagnostic challenges are associated with distinguishing benign spindle cell proliferations from high grade sarcoma due to histologic and immunohistochemical overlap. In addition to benign and malignant categories, contemporary classification of mesenchymal neoplasms emphasizes lesions with intermediate biologic potential, including those that are locally aggressive or rarely metastasize. There are circumstances in which pathologists can render only descriptive diagnoses without precise classification. New discoveries in molecular genetics have clarified some of these problematic lesions. Furthermore, there are newly described entities that practicing pathologists should be aware of so that tumors are appropriately diagnosed and optimally treated. This course, presented by expert mentors and educators, explores a comprehensive panorama of lesions and anatomic sites.
This course is designed for general pathologists, practicing surgical pathologists, senior residents and pathologists with special interest in head and neck pathology.
Upon completion of this educational activity, learners will be able to:
- Recognize common and problematic mesenchymal lesions of different anatomic sites
- Become familiar with recently described diagnostic entities
- Design a panel of ancillary testing that aids in the diagnosis of mesenchymal tumors
- Avoid pitfalls caused by erroneous interpretation of immunohistochemical stains
- Understand the diagnostic criteria for malignancy and for the classification of mesenchymal neoplasms
Details : 13 Videos , 6 PDF
Price : $ 100